<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ther Clin Risk Manag</journal-id><journal-id journal-id-type="iso-abbrev">Ther Clin Risk Manag</journal-id><journal-id journal-id-type="publisher-id">Therapeutics and Clinical Risk Management</journal-id><journal-title-group><journal-title>Therapeutics and Clinical Risk Management</journal-title></journal-title-group><issn pub-type="ppub">1176-6336</issn><issn pub-type="epub">1178-203X</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24124372</article-id><article-id pub-id-type="pmc">3794888</article-id><article-id pub-id-type="doi">10.2147/TCRM.S45802</article-id><article-id pub-id-type="publisher-id">tcrm-9-371</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Randomized controlled study of the antipyretic efficacy of oral paracetamol, intravenous paracetamol, and intramuscular diclofenac in patients presenting with fever to the emergency department</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Paramba</surname><given-names>Firjeeth C</given-names></name><xref ref-type="aff" rid="af1-tcrm-9-371">1</xref><xref ref-type="corresp" rid="c1-tcrm-9-371"/></contrib><contrib contrib-type="author"><name><surname>Naushad</surname><given-names>Vamanjore A</given-names></name><xref ref-type="aff" rid="af1-tcrm-9-371">1</xref></contrib><contrib contrib-type="author"><name><surname>Purayil</surname><given-names>Nishan</given-names></name><xref ref-type="aff" rid="af1-tcrm-9-371">1</xref></contrib><contrib contrib-type="author"><name><surname>Mohammed</surname><given-names>Osama H</given-names></name><xref ref-type="aff" rid="af1-tcrm-9-371">1</xref></contrib><contrib contrib-type="author"><name><surname>Chandra</surname><given-names>Prem</given-names></name><xref ref-type="aff" rid="af2-tcrm-9-371">2</xref></contrib></contrib-group><aff id="af1-tcrm-9-371"><label>1</label>Emergency Department, Alkhor Hospital, Qatar</aff><aff id="af2-tcrm-9-371"><label>2</label>Medical Research Department, Hamad Medical Corporation, Qatar</aff><author-notes><corresp id="c1-tcrm-9-371">Correspondence: Firjeeth C Paramba, Emergency Department, Alkhor Hospital, Hamad Medical Corporation, PO Box 3050, Qatar, Tel +97 455 660 720, Fax +97 444 745 634, Email <email>cpfirjith@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><!--Dove Press titles changed from ppub to collections in 2009.
								Fake ppub written to satisfy Coll Date Type=ppub--><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>03</day><month>10</month><year>2013</year></pub-date><volume>9</volume><fpage>371</fpage><lpage>376</lpage><permissions><copyright-statement>&#x000a9; 2013 Paramba et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License</copyright-statement><copyright-year>2013</copyright-year><license><license-p>The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.</license-p></license></permissions><abstract><sec><title>Background</title><p>Fever is a common problem in adults visiting the emergency department. Extensive studies have been done in children comparing the efficacy of various antipyretics. However, studies on the efficacy of antipyretic drugs in adults are very scarce. To the best of our knowledge, no controlled trial has been carried out comparing the antipyretic efficacy of paracetamol (oral and intravenous) and intramuscular diclofenac in adults.</p></sec><sec><title>Methods</title><p>In this parallel-group, open-label trial, participants aged 14&#x02013;75 years presenting with fever who had a temperature of more than 38.5&#x000b0;C were enrolled and treated. Participants were randomly allocated to receive treatment with 1,000 mg oral paracetamol (n = 145), 1,000 mg intravenous paracetamol (n = 139), or 75 mg intramuscular diclofenac (n = 150). The primary outcome was degree of reduction in mean oral temperature at 90 minutes. The efficacy of diclofenac versus oral and intravenous paracetamol was assessed by superiority comparison. Analysis was done using intention to treat principles.</p></sec><sec><title>Results</title><p>After 90 minutes, all three groups showed a significant reduction in mean temperature, with intramuscular diclofenac showing the greatest reduction (&#x02212;1.44 &#x000b1; 0.43, 95% confidence interval [CI] &#x02212;1.4 to &#x02212;2.5) and oral paracetamol the least (&#x02212;1.08 &#x000b1; 0.51, 95% CI &#x02212;0.99 to &#x02212;2.2). After 120 minutes, there was a significant difference observed in the mean change from baseline temperature between the three treatment groups (<italic>P</italic> &#x0003c; 0.0001). Significant changes in temperature were observed in favor of intramuscular diclofenac over oral and intravenous paracetamol at each time point from 60 minutes through 120 minutes inclusive.</p></sec><sec><title>Conclusion</title><p>Both intramuscular diclofenac and intravenous paracetamol showed superior antipyretic activity than oral paracetamol. However, in view of its ease of administration, intramuscular diclofenac can be used as a first-choice antipyretic in febrile adults in the emergency department.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>antipyretic</kwd><kwd>intramuscular</kwd><kwd>intravenous</kwd><kwd>paracetamol</kwd><kwd>diclofenac</kwd><kwd>emergency department</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Fever accounts for a substantial proportion of adult emergency consultations or visits. It is one of the leading patient complaints aside from abdominal pain and chest pain in all emergency department visits.<xref ref-type="bibr" rid="b1-tcrm-9-371">1</xref> Although there may be physiologic benefits of fever, it also associated with arthralgia, myalgia, nausea, and vomiting. Treatment with antipyretics improves these accompanying symptoms<xref ref-type="bibr" rid="b2-tcrm-9-371">2</xref> and reduces patient discomfort.<xref ref-type="bibr" rid="b3-tcrm-9-371">3</xref> Both pharmacologic and nonpharmacologic methods like tepid sponging<xref ref-type="bibr" rid="b4-tcrm-9-371">4</xref> have been used to reduce body temperature in febrile patients. Extensive studies have been done in children comparing the efficacy of various antipyretics. These have included paracetamol, ibuprofen, nimesulide, ketoprofen, propacetamol, and dipyrone.<xref ref-type="bibr" rid="b5-tcrm-9-371">5</xref>&#x02013;<xref ref-type="bibr" rid="b19-tcrm-9-371">19</xref></p><p>Studies on the efficacy of antipyretic drugs in adults are very scarce. Most of the available studies on acetaminophen were carried out in endotoxin-induced febrile models<xref ref-type="bibr" rid="b20-tcrm-9-371">20</xref>&#x02013;<xref ref-type="bibr" rid="b22-tcrm-9-371">22</xref> and others in intensive care patients.<xref ref-type="bibr" rid="b23-tcrm-9-371">23</xref> Few studies have been done on oral diclofenac using varying doses<xref ref-type="bibr" rid="b24-tcrm-9-371">24</xref> or comparing it with ibuprofen<xref ref-type="bibr" rid="b25-tcrm-9-371">25</xref> or acetylsalicylic acid.<xref ref-type="bibr" rid="b26-tcrm-9-371">26</xref> Intravenous ketorolac has also been studied as an antipyretic in adults.<xref ref-type="bibr" rid="b27-tcrm-9-371">27</xref> To the best of our knowledge, no controlled trial has been carried out comparing the antipyretic efficacy of paracetamol (both oral and intravenous) and intramuscular diclofenac in adults. Therefore, we decided to compare the antipyretic efficacy of oral and intravenous paracetamol with that of intramuscular diclofenac in febrile adults in the emergency department.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec sec-type="methods|subjects"><title>Study design, participants, and randomization</title><p>A randomized controlled clinical trial was conducted in the emergency department at Alkhor Hospital, Hamad Medical Corporation, in the state of Qatar from June 2008 to December 2011. Adults aged 14&#x02013;75 years were included if they had an oral temperature of more than 38.5&#x000b0;C. A complete clinical assessment including past and present medical history was performed. The main exclusion criteria were a history of allergy to any of the trial medications, antipyretics within the previous 8 hours, renal, hepatic or hematologic disorders, bronchial asthma, peptic ulcer disease, and frequent vomiting. Pregnant or lactating women were also excluded. The study was approved by the local ethics committee at the Medical Research Center, Hamad Medical Corporation (number 9070/09) and was done in accordance with the principles of the Declaration of Helsinki and guidelines for Good Clinical Practice. All patients provided their written informed consent prior to enrollment. The trial is registered with ClinicalTrials.gov (NCT01891435).</p><p>The randomization sequence list was created using a computerized random number generator. Participants were assigned to one of the three treatment groups using an equal allocation ratio of 1:1:1. The allocation sequence was concealed from the investigators enrolling the patients in sequentially numbered and sealed envelopes. The corresponding envelopes were opened only after the participants completed all baseline assessments and it was time to allocate the intervention. Randomization codes were kept secure until all data entry was complete.</p></sec><sec><title>Sample size</title><p>The primary outcome measure was the mean oral temperature decrease from baseline at 90 minutes. It was assumed that the mean oral temperature decrease for the three treatments was 1.4&#x000b0;C (intramuscular diclofenac), 1.22&#x000b0;C (intravenous paracetamol), and 1.1&#x000b0;C (oral paracetamol), respectively, with a constant standard deviation of 0.5&#x000b0;C for the three treatments. The sample size needed to achieve the desired power of 80% (&#x003b2; = 0.20) at the 5% (&#x003b1; = 0.05) level of significance was 130 patients per treatment group.</p></sec><sec sec-type="methods"><title>Procedures</title><p>Baseline oral temperature was recorded at enrollment. Patients were randomly assigned to receive oral paracetamol 1,000 mg, intravenous paracetamol 1,000 mg, or intramuscular diclofenac sodium 75 mg supplied from the hospital pharmacy free of cost to the patients. Intravenous paracetamol was given as an infusion over 15 minutes. Oral temperature was recorded at 30, 60, 90, and 120 minutes after drug administration. All temperature recordings were done using a standard thermometer. The primary outcome was the degree of reduction in mean oral temperature at 90 minutes and the secondary outcome was the degree of reduction in mean oral temperature at 30, 60, and 120 minutes. Patients were also monitored for any adverse effects pertaining to the trial medications.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Categoric and continuous values were expressed as the frequency (percentage) and mean &#x000b1; standard deviation. Descriptive statistics were used to summarize all demographic and other clinical characteristics of the patients. Baseline participant characteristics in the three groups were compared using one-way analysis of variance (ANOVA) for continuous variables and chi-square tests for categoric variables. For the primary outcome variable, ie, reduction in mean oral temperature at 90 minutes was compared using one-way ANOVA. The results are presented with the associated 95% confidence interval. Where an overall group difference was found to be statistically significant, pairwise comparisons were made using the appropriate post hoc test. Reduction in mean oral temperature at 30, 60, and 120 minutes was analyzed using repeated-measures ANOVA. Means of quantitative variables between two independent groups were analyzed using the unpaired <italic>t</italic>-test. Associations between two or more qualitative or categoric variables were assessed using the chi-square test. For small cell frequencies, the chi-square test was used with a continuity correction factor. Pictorial presentations of the key results were made using appropriate statistical graphs. A two-sided <italic>P</italic>-value &#x0003c; 0.05 was considered to be statistically significant. All statistical analyses were done using Statistical Package for the Social Sciences version 19 software (SPSS Inc., Chicago, IL, USA).</p></sec></sec><sec sec-type="results"><title>Results</title><p>Six hundred patients were screened for study eligibility (<xref ref-type="fig" rid="f1-tcrm-9-371">Figure 1</xref>). Of these, 166 patients could not participate for various reasons (140 did not fulfill the inclusion criteria or met an exclusion criterion and 26 did not give their consent to participate in the trial). Therefore, a total of 434 adults were enrolled, randomized, and received the study medications, ie, oral paracetamol (n = 145), intravenous paracetamol (n = 139), and intramuscular diclofenac (n = 150). Baseline demographic and clinical characteristics were similar across the three treatment groups (<italic>P</italic> &#x0003e; 0.05, <xref ref-type="table" rid="t1-tcrm-9-371">Table 1</xref>). The majority of the study subjects enrolled were males. This can be attributed to the location of the hospital, which caters mainly for the migrant labor community of the surrounding industrial area. The mean patient age was 36. 1 &#x000b1; 15.81 years. Mean oral temperature at baseline was similar across the three treatment groups. <xref ref-type="fig" rid="f1-tcrm-9-371">Figure 1</xref> shows the enrollment of participants through each stage of the trial.</p><p>After 90 minutes, all three groups showed a significant reduction in mean temperature, with intramuscular diclofenac showing the greatest (&#x02212;1.44 &#x000b1; 0.43, 95% confidence interval [CI] &#x02212;1.4 to &#x02212;2.5) and oral paracetamol the least (&#x02212;1.08 &#x000b1; 0.51, 95% CI &#x02212;0.99 to &#x02212;2.2). After 120 minutes, there was a significant difference observed in the mean change from baseline temperatures between the three treatment groups (<italic>P</italic> &#x0003c; 0.0001). Significant changes in temperature were observed in favor of intramuscular diclofenac over oral and intravenous paracetamol at each time point from 60 minutes through 120 minutes inclusive (<xref ref-type="table" rid="t3-tcrm-9-371">Table 3</xref>). Repeated-measures ANOVA revealed a significant reduction in the change from mean baseline temperature within each treatment group, particularly at 60, 90, and 120 minutes (<xref ref-type="table" rid="t2-tcrm-9-371">Table 2</xref> and <xref ref-type="fig" rid="f2-tcrm-9-371">Figure 2</xref>). Patients who received intravenous fluids showed a significantly higher reduction in mean temperature from baseline, particularly at 30 minutes (&#x02212;0.45 &#x000b1; 0.38 versus &#x02212;0.33 &#x000b1; 0.34; <italic>P</italic> = 0.002) and 120 minute (&#x02212;1.7 &#x000b1; 0.59 versus &#x02212;1.5 &#x000b1; 0.51; <italic>P</italic> = 0.030) Reduction in mean temperature at the various time points was not significantly different among patients receiving antibiotics.</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Fever occurs as a response to a variety of infectious and noninfectious inflammatory conditions. It is due to abnormally high hypothalamic thermostasis caused by the actions of interleukin or pyrogenic cytokines on the hypothalamic thermoregulatory center. Although treating the underlying cause should be the primary objective, reducing the fever is also important because this decreases constitutional symptoms and the discomfort to the patient.</p><p>We believe that this is the first study to compare directly the antipyretic efficacy of intramuscular diclofenac and paracetamol (both oral and intravenous), which are the two drugs commonly used in adults. Our results are in partial agreement with the findings of a previous study done by Peacock et al<xref ref-type="bibr" rid="b20-tcrm-9-371">20</xref> comparing intravenous and oral paracetamol, which showed a statistically significant difference in temperature in the first 2 hours favoring intravenous over oral acetaminophen. Similarly, another study done by Kett et al<xref ref-type="bibr" rid="b21-tcrm-9-371">21</xref> showed a significant reduction in temperature at 30 minutes from baseline by intravenous acetaminophen 1,000 mg in comparison with placebo. However, both these studies were done using endotoxin-induced febrile models. Another study done in an endotoxin-induced model showed oral acetaminophen to have a greater effect than aspirin.<xref ref-type="bibr" rid="b22-tcrm-9-371">22</xref></p><p>Gehanno et al compared the antipyretic and analgesic effects of oral paracetamol with that of various doses of oral diclofenac. They found that diclofenac at doses of 12. 5 mg and 25 mg had a greater analgesic and antipyretic effect than paracetamol.<xref ref-type="bibr" rid="b24-tcrm-9-371">24</xref></p><p>There has been no study done on the antipyretic effect of intramuscular diclofenac. However, a study comparing three intravenous antipyretics, ie, diclofenac 75 mg, metamizole 2,500 mg or 1,000 mg, and propacetamol 2,000 mg or 1,000 mg in hematology/oncology patients found metamizole to be the most effective, while propacetamol 1,000 mg had the least antipyretic efficacy. However, major drawbacks of this study are that it was nonrandomized and done in cancer patients.<xref ref-type="bibr" rid="b2-tcrm-9-371">2</xref> The limitation of our study is that the majority of the subjects enrolled were males. This can be attributed to the location of the hospital which mainly caters for the migrant labor community in the surrounding industrial area.</p></sec><sec><title>Conclusion</title><p>In this study, intramuscular diclofenac and intravenous paracetamol were more effective in achieving a significant reduction in temperature at each time point from 60 minutes through 120 minutes inclusive. Of the two agents, intramuscular diclofenac showed the greatest effect. Beyond 90 minutes, all three drugs showed significant antipyretic activity, with oral paracetamol having the least effect and intramuscular diclofenac having the greatest effect. Hence we conclude that, in the emergency department, intramuscular diclofenac can be used as an antipyretic of choice to reduce temperature within a short time. However, if rapid reduction is not required, patients can be treated with oral paracetamol.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank the doctors and nursing staff of the emergency department, Alkhor Hospital, for their support and cooperation during this study.</p></ack><fn-group><fn><p><bold>Disclosure</bold></p><p>The authors report no conflicts of interest in this work.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-tcrm-9-371"><label>1</label><mixed-citation publication-type="webpage"><source>National Hospital Ambulatory Medical Care Survey 2010: Emergency Department Summary</source><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2010_ed_web_tables.pdf">http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2010_ed_web_tables.pdf</ext-link></comment>Accessed <date-in-citation>August 8, 2013</date-in-citation></mixed-citation></ref><ref id="b2-tcrm-9-371"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oborilov&#x000e1;</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>J</given-names></name><name><surname>Posp&#x000ed;sil</surname><given-names>Z</given-names></name><name><surname>Kor&#x000ed;stek</surname><given-names>Z</given-names></name></person-group><article-title>Symptomatic intravenous antipyretic therapy: efficacy of metamizol, diclofenac, and propacetamol</article-title><source>J Pain Symptom Manage</source><year>2002</year><volume>24</volume><fpage>608</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">12551812</pub-id></element-citation></ref><ref id="b3-tcrm-9-371"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>MS</given-names></name><name><surname>Naimark</surname><given-names>LE</given-names></name><name><surname>Roberts-Brauer</surname><given-names>R</given-names></name><name><surname>McDougall</surname><given-names>A</given-names></name><name><surname>Leduc</surname><given-names>DG</given-names></name></person-group><article-title>Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin</article-title><source>Lancet</source><year>1991</year><volume>337</volume><fpage>591</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">1671951</pub-id></element-citation></ref><ref id="b4-tcrm-9-371"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Vijaykumar</surname><given-names>C</given-names></name><name><surname>Naik</surname><given-names>R</given-names></name><name><surname>Antonisamy</surname><given-names>B</given-names></name></person-group><article-title>Comparative effectiveness of tepid sponging and antipyretic drug versus only antipyretic drug in the management of fever among children: a randomized controlled trial</article-title><source>Indian Pediatr</source><year>2009</year><volume>46</volume><fpage>133</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">19242030</pub-id></element-citation></ref><ref id="b5-tcrm-9-371"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>MT</given-names></name><name><surname>Sylvie</surname><given-names>T</given-names></name><name><surname>Philippe</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Antipyretic efficacy of an initial 30 mg/kg loading dose of acetaminophen versus a 15 mg/kg maintenance dose</article-title><source>Pediatrics</source><year>2001</year><volume>108</volume><fpage>e73</fpage><pub-id pub-id-type="pmid">11581481</pub-id></element-citation></ref><ref id="b6-tcrm-9-371"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karbasi</surname><given-names>SA</given-names></name><name><surname>Modares-Mosadegh</surname><given-names>M</given-names></name><name><surname>Golestan</surname><given-names>M</given-names></name></person-group><article-title>Comparison of antipyretic effectiveness of equal doses of rectal and oral acetaminophen in children</article-title><source>J Pediatr (Rio J)</source><year>2010</year><volume>86</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">20436978</pub-id></element-citation></ref><ref id="b7-tcrm-9-371"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>IM</given-names></name><name><surname>Sturgis</surname><given-names>SA</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Watts</surname><given-names>H</given-names></name><name><surname>Berlin</surname><given-names>CM</given-names><suffix>Jr</suffix></name></person-group><article-title>Efficacy of standard doses of ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile children</article-title><source>Clin Ther</source><year>2010</year><volume>32</volume><fpage>2433</fpage><lpage>2440</lpage><pub-id pub-id-type="pmid">21353111</pub-id></element-citation></ref><ref id="b8-tcrm-9-371"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maryam</surname><given-names>S</given-names></name><name><surname>Raheb</surname><given-names>G</given-names></name><name><surname>Semira</surname><given-names>M</given-names></name><name><surname>Setareh</surname><given-names>A</given-names></name><name><surname>Parviz</surname><given-names>B</given-names></name></person-group><article-title>A comparison of the antipyretic effect antipyretic acetaminophen and ibuprofen in febrile children hospitalized at Amir-al-Momenin Hospital in Semnan</article-title><source>Iran J Pharmacol Ther</source><year>2007</year><volume>6</volume><issue>2</issue><fpage>213</fpage><lpage>215</lpage></element-citation></ref><ref id="b9-tcrm-9-371"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nabulsi</surname><given-names>MM</given-names></name><name><surname>Tamim</surname><given-names>H</given-names></name><name><surname>Mahfoud</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Alternating ibuprofen and acetaminophen in the treatment of febrile children: a pilot study [ISRCTN30487061]</article-title><source>BMC Med</source><year>2006</year><volume>4</volume><fpage>4</fpage><pub-id pub-id-type="pmid">16515705</pub-id></element-citation></ref><ref id="b10-tcrm-9-371"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Esch</surname><given-names>A</given-names></name><name><surname>Van Steensel-Moll</surname><given-names>HA</given-names></name><name><surname>Steyerberg</surname><given-names>EW</given-names></name><name><surname>Offringa</surname><given-names>M</given-names></name><name><surname>Habbema</surname><given-names>JD</given-names></name><name><surname>Derksen-Lubsen</surname><given-names>G</given-names></name></person-group><article-title>Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures</article-title><source>Arch Pediatr Adolesc Med</source><year>1995</year><volume>149</volume><fpage>632</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">7767417</pub-id></element-citation></ref><ref id="b11-tcrm-9-371"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>AD</given-names></name><name><surname>Redmond</surname><given-names>NM</given-names></name><name><surname>Costelloe</surname><given-names>C</given-names></name><etal/></person-group><article-title>Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomized controlled trial</article-title><source>Health Technol Assess</source><year>2009</year><volume>13</volume><fpage>iii</fpage><lpage>iv</lpage><lpage>ix</lpage><lpage>x</lpage><lpage>1</lpage><lpage>163</lpage><pub-id pub-id-type="pmid">19454182</pub-id></element-citation></ref><ref id="b12-tcrm-9-371"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntyre</surname><given-names>J</given-names></name><name><surname>Hull</surname><given-names>D</given-names></name></person-group><article-title>Comparing efficacy and tolerability of ibuprofen and paracetamol in fever</article-title><source>Arch Dis Child</source><year>1996</year><volume>74</volume><fpage>164</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">8660083</pub-id></element-citation></ref><ref id="b13-tcrm-9-371"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinh</surname><given-names>H</given-names></name><name><surname>Parry</surname><given-names>CM</given-names></name><name><surname>Hanh</surname><given-names>VT</given-names></name><etal/></person-group><article-title>Double blind comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever</article-title><source>Pediatr Infect Dis J</source><year>2004</year><volume>23</volume><fpage>226</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">15014297</pub-id></element-citation></ref><ref id="b14-tcrm-9-371"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lal</surname><given-names>A</given-names></name><name><surname>Gomber</surname><given-names>S</given-names></name><name><surname>Talukdar</surname><given-names>B</given-names></name></person-group><article-title>Antipyretic effects of nimesulide, paracetamol and ibuprofen-paracetamol</article-title><source>Indian J Pediatr</source><year>2000</year><volume>67</volume><fpage>865</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">11262983</pub-id></element-citation></ref><ref id="b15-tcrm-9-371"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>SK</given-names></name><name><surname>Sharma</surname><given-names>J</given-names></name><name><surname>Batra</surname><given-names>B</given-names></name><name><surname>Paul</surname><given-names>E</given-names></name><name><surname>Anand</surname><given-names>K</given-names></name><name><surname>Sharma</surname><given-names>D</given-names></name></person-group><article-title>Comparison of antipyretic effect of nimesulide and paracetamol in children attending a secondary level hospital</article-title><source>Indian Pediatr</source><year>2002</year><volume>39</volume><fpage>473</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">12037280</pub-id></element-citation></ref><ref id="b16-tcrm-9-371"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokki</surname><given-names>H</given-names></name><name><surname>Kokki</surname><given-names>M</given-names></name></person-group><article-title>Ketoprofen versus paracetamol or ibuprofen in the management of fever: results of two randomized, double-blind, double-dummy, parallel-group, repeated-dose, multicentre, phase III studies in children</article-title><source>Clin Drug Investig</source><year>2010</year><volume>30</volume><fpage>375</fpage><lpage>386</lpage></element-citation></ref><ref id="b17-tcrm-9-371"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walson</surname><given-names>PD</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Chesney</surname><given-names>R</given-names></name><name><surname>Rodarte</surname><given-names>A</given-names></name></person-group><article-title>Antipyretic efficacy and tolerability of a single intravenous dose of the acetaminophen prodrug propacetamol in children: a randomized, double blind placebo controlled trial</article-title><source>Clin Ther</source><year>2006</year><volume>28</volume><fpage>762</fpage><lpage>769</lpage><pub-id pub-id-type="pmid">16861098</pub-id></element-citation></ref><ref id="b18-tcrm-9-371"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prado</surname><given-names>J</given-names></name><name><surname>Daza</surname><given-names>R</given-names></name><name><surname>Chumbes</surname><given-names>O</given-names></name><name><surname>Loayza</surname><given-names>I</given-names></name><name><surname>Huicho</surname><given-names>L</given-names></name></person-group><article-title>Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: a randomized controlled trial</article-title><source>Sao Paulo Med J</source><year>2006</year><volume>124</volume><fpage>136</fpage><lpage>140</lpage></element-citation></ref><ref id="b19-tcrm-9-371"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celebi</surname><given-names>S</given-names></name><name><surname>Hacimustafaoglu</surname><given-names>M</given-names></name><name><surname>Arisoy</surname><given-names>ES</given-names></name><etal/></person-group><article-title>Antipyretic effect of ketoprofen</article-title><source>Indian J Pediatr</source><year>2009</year><volume>76</volume><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">19129989</pub-id></element-citation></ref><ref id="b20-tcrm-9-371"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peacock</surname><given-names>WF</given-names></name><name><surname>Breitmeyer</surname><given-names>JB</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>WB</given-names></name><name><surname>Royal</surname><given-names>MA</given-names></name></person-group><article-title>A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever</article-title><source>Acad Emerg Med</source><year>2011</year><volume>18</volume><fpage>360</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">21496138</pub-id></element-citation></ref><ref id="b21-tcrm-9-371"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kett</surname><given-names>DH</given-names></name><name><surname>Bretmeyer</surname><given-names>JB</given-names></name><name><surname>Ang</surname><given-names>R</given-names></name><name><surname>Royal</surname><given-names>MA</given-names></name></person-group><article-title>A randomized study of the efficacy and safety of intravenous acetaminophen vs intravenous placebo for the treatment of fever</article-title><source>Clin Pharmacol Ther</source><year>2011</year><volume>90</volume><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21544074</pub-id></element-citation></ref><ref id="b22-tcrm-9-371"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pernerstorfer</surname><given-names>T</given-names></name><name><surname>Schmid</surname><given-names>R</given-names></name><name><surname>Bieglmayer</surname><given-names>C</given-names></name><name><surname>Eichler</surname><given-names>HG</given-names></name><name><surname>Kapiotis</surname><given-names>S</given-names></name><name><surname>Jilma</surname><given-names>B</given-names></name></person-group><article-title>Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double blind placebo controlled trial</article-title><source>Clin Pharmacol Ther</source><year>1999</year><volume>66</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">10430109</pub-id></element-citation></ref><ref id="b23-tcrm-9-371"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullins</surname><given-names>ME</given-names></name><name><surname>Empey</surname><given-names>M</given-names></name><name><surname>Jaramillo</surname><given-names>D</given-names></name><etal/></person-group><article-title>A prospective randomized study to evaluate the antipyretic effect of the combination of acetaminophen and ibuprofen in neurological ICU patients</article-title><source>Neurocrit Care</source><year>2011</year><volume>15</volume><fpage>375</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">21503807</pub-id></element-citation></ref><ref id="b24-tcrm-9-371"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehanno</surname><given-names>P</given-names></name><name><surname>Dreiser</surname><given-names>RL</given-names></name><name><surname>Ionescu</surname><given-names>E</given-names></name><name><surname>Gold</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>JM</given-names></name></person-group><article-title>Lowest effective single dose diclofenac for antipyretic and analgesic effects in acute febrile sore throat</article-title><source>Clin Drug Investig</source><year>2003</year><volume>23</volume><fpage>263</fpage><lpage>271</lpage></element-citation></ref><ref id="b25-tcrm-9-371"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grebe</surname><given-names>W</given-names></name><name><surname>Ionescu</surname><given-names>E</given-names></name><name><surname>Gold</surname><given-names>MS</given-names></name><name><surname>Liu</surname><given-names>JM</given-names></name><name><surname>Frank</surname><given-names>WO</given-names></name></person-group><article-title>A multicentre, randomized, double-blind, double-dummy, placebo and active controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza like symptoms</article-title><source>Clin Ther</source><year>2003</year><volume>25</volume><fpage>444</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">12749506</pub-id></element-citation></ref><ref id="b26-tcrm-9-371"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettini</surname><given-names>R</given-names></name><name><surname>Grossi</surname><given-names>E</given-names></name><name><surname>Rapazzini</surname><given-names>P</given-names></name><name><surname>Giardina</surname><given-names>G</given-names></name></person-group><article-title>Diclofenac sodium versus acetylsalicylic acid: a randomized study in febrile patients</article-title><source>J Int Med Res</source><year>1986</year><volume>14</volume><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">3516755</pub-id></element-citation></ref><ref id="b27-tcrm-9-371"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>HB</given-names></name><name><surname>Sara</surname><given-names>NN</given-names></name><name><surname>Marc</surname><given-names>NR</given-names></name><name><surname>Howard</surname><given-names>AS</given-names></name></person-group><article-title>Antipyretic effectiveness of intravenous ketorolac tromethamine</article-title><source>J Emerg Med</source><year>2004</year><volume>26</volume><fpage>407</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">15093845</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-tcrm-9-371" position="float"><label>Figure 1</label><caption><p>Patient flow and enrollment chart.</p><p><bold>Abbreviations:</bold> IM, intramuscular; IV, intravenous.</p></caption><graphic xlink:href="tcrm-9-371Fig1"/></fig><fig id="f2-tcrm-9-371" position="float"><label>Figure 2</label><caption><p>Mean temperatures at different time points for the three treatment groups.</p><p><bold>Abbreviation:</bold> IV, intravenous.</p></caption><graphic xlink:href="tcrm-9-371Fig2"/></fig><table-wrap id="t1-tcrm-9-371" position="float"><label>Table 1</label><caption><p>Baseline demographic and clinical characteristics of enrolled patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Variables</th><th align="left" valign="top" rowspan="1" colspan="1">IM diclofenac<break/>(n = 150)</th><th align="left" valign="top" rowspan="1" colspan="1">Oral paracetamol<break/>(n = 145)</th><th align="left" valign="top" rowspan="1" colspan="1">IV paracetamol<break/>(n = 139)</th><th align="left" valign="top" rowspan="1" colspan="1">Total<break/>(n = 434)</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="left" valign="top" rowspan="1" colspan="1">35.5 &#x000b1; 14.24</td><td align="left" valign="top" rowspan="1" colspan="1">36.2 &#x000b1; 15.35</td><td align="left" valign="top" rowspan="1" colspan="1">36.4 &#x000b1; 14.98</td><td align="left" valign="top" rowspan="1" colspan="1">36.1 &#x000b1; 15.81</td><td align="left" valign="top" rowspan="1" colspan="1">0. 695</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Gender</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="left" valign="top" rowspan="1" colspan="1">150 (100.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">144 (99.3)</td><td align="left" valign="top" rowspan="1" colspan="1">139 (100.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">433 (99.8%)</td><td rowspan="2" align="left" valign="top" colspan="1">0. 881</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="left" valign="top" rowspan="1" colspan="1">0.0 (0.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">1 (0.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">0.0 (0.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">1 (0.2%)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">IV fluids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">36 (24.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (19.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">44 (31.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">108 (24.9%)</td><td rowspan="2" align="left" valign="top" colspan="1">0. 054</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="top" rowspan="1" colspan="1">114 (76.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">117 (80.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">95 (68.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">326 (75.1%)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Antibiotic</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="left" valign="top" rowspan="1" colspan="1">9 (6.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">15 (10.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">20 (14.4%)</td><td align="left" valign="top" rowspan="1" colspan="1">44 (10.2%)</td><td rowspan="2" align="left" valign="top" colspan="1">0. 064</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="left" valign="top" rowspan="1" colspan="1">141 (94.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">130 (89.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">119 (85.6%)</td><td align="left" valign="top" rowspan="1" colspan="1">389 (89.8%)</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Nationality</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Indian</td><td align="left" valign="top" rowspan="1" colspan="1">45 (30.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">60 (41.4%)</td><td align="left" valign="top" rowspan="1" colspan="1">46 (33.1%)</td><td align="left" valign="top" rowspan="1" colspan="1">151 (34.8%)</td><td rowspan="6" align="left" valign="top" colspan="1">0. 238</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Nepalese</td><td align="left" valign="top" rowspan="1" colspan="1">68 (45.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">49 (33.8%)</td><td align="left" valign="top" rowspan="1" colspan="1">51 (36.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">168 (38.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pakistani</td><td align="left" valign="top" rowspan="1" colspan="1">10 (6.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">8 (5.5%)</td><td align="left" valign="top" rowspan="1" colspan="1">16 (11.5%)</td><td align="left" valign="top" rowspan="1" colspan="1">34 (7.8%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bangladeshi</td><td align="left" valign="top" rowspan="1" colspan="1">12 (8.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">10 (6.9%)</td><td align="left" valign="top" rowspan="1" colspan="1">9 (6.5%)</td><td align="left" valign="top" rowspan="1" colspan="1">31 (7.1%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Sri Lankan</td><td align="left" valign="top" rowspan="1" colspan="1">11 (7.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">8 (5.5%)</td><td align="left" valign="top" rowspan="1" colspan="1">9 (6.5%)</td><td align="left" valign="top" rowspan="1" colspan="1">28 (6.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Others</td><td align="left" valign="top" rowspan="1" colspan="1">4 (2.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">10 (6.9%)</td><td align="left" valign="top" rowspan="1" colspan="1">8 (5.8%)</td><td align="left" valign="top" rowspan="1" colspan="1">22 (5.1%)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-tcrm-9-371"><p><bold>Abbreviations:</bold> IV, intravenous; IM, intramuscular.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-tcrm-9-371" position="float"><label>Table 2</label><caption><p>Comparison of mean temperature at different time points between the three treatment groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Time (minutes)</th><th colspan="3" align="left" valign="top" rowspan="1">IM diclofenac
<hr/></th><th colspan="3" align="left" valign="top" rowspan="1">Oral paracetamol
<hr/></th><th colspan="3" align="left" valign="top" rowspan="1">IV paracetamol
<hr/></th><th align="left" valign="top" rowspan="2" colspan="1"><italic>P</italic>-value</th></tr><tr><th align="left" valign="top" rowspan="1" colspan="1">n</th><th align="left" valign="top" rowspan="1" colspan="1">Mean</th><th align="left" valign="top" rowspan="1" colspan="1">SD</th><th align="left" valign="top" rowspan="1" colspan="1">n</th><th align="left" valign="top" rowspan="1" colspan="1">Mean</th><th align="left" valign="top" rowspan="1" colspan="1">SD</th><th align="left" valign="top" rowspan="1" colspan="1">n</th><th align="left" valign="top" rowspan="1" colspan="1">Mean</th><th align="left" valign="top" rowspan="1" colspan="1">SD</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="left" valign="top" rowspan="1" colspan="1">150</td><td align="left" valign="top" rowspan="1" colspan="1">39.27</td><td align="left" valign="top" rowspan="1" colspan="1">0.438</td><td align="left" valign="top" rowspan="1" colspan="1">145</td><td align="left" valign="top" rowspan="1" colspan="1">39.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.473</td><td align="left" valign="top" rowspan="1" colspan="1">139</td><td align="left" valign="top" rowspan="1" colspan="1">39.38</td><td align="left" valign="top" rowspan="1" colspan="1">0.527</td><td align="left" valign="top" rowspan="1" colspan="1">0.112</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">150</td><td align="left" valign="top" rowspan="1" colspan="1">38.88</td><td align="left" valign="top" rowspan="1" colspan="1">0.421</td><td align="left" valign="top" rowspan="1" colspan="1">145</td><td align="left" valign="top" rowspan="1" colspan="1">39.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.526</td><td align="left" valign="top" rowspan="1" colspan="1">139</td><td align="left" valign="top" rowspan="1" colspan="1">38.92</td><td align="left" valign="top" rowspan="1" colspan="1">0.463</td><td align="left" valign="top" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">60</td><td align="left" valign="top" rowspan="1" colspan="1">150</td><td align="left" valign="top" rowspan="1" colspan="1">38.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.394</td><td align="left" valign="top" rowspan="1" colspan="1">145</td><td align="left" valign="top" rowspan="1" colspan="1">38.59</td><td align="left" valign="top" rowspan="1" colspan="1">0.487</td><td align="left" valign="top" rowspan="1" colspan="1">139</td><td align="left" valign="top" rowspan="1" colspan="1">38.37</td><td align="left" valign="top" rowspan="1" colspan="1">0.424</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">143</td><td align="left" valign="top" rowspan="1" colspan="1">37.84</td><td align="left" valign="top" rowspan="1" colspan="1">0.407</td><td align="left" valign="top" rowspan="1" colspan="1">142</td><td align="left" valign="top" rowspan="1" colspan="1">38.21</td><td align="left" valign="top" rowspan="1" colspan="1">0.542</td><td align="left" valign="top" rowspan="1" colspan="1">137</td><td align="left" valign="top" rowspan="1" colspan="1">38.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.443</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">120</td><td align="left" valign="top" rowspan="1" colspan="1">112</td><td align="left" valign="top" rowspan="1" colspan="1">37.55</td><td align="left" valign="top" rowspan="1" colspan="1">0.387</td><td align="left" valign="top" rowspan="1" colspan="1">118</td><td align="left" valign="top" rowspan="1" colspan="1">38.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.436</td><td align="left" valign="top" rowspan="1" colspan="1">118</td><td align="left" valign="top" rowspan="1" colspan="1">37.80</td><td align="left" valign="top" rowspan="1" colspan="1">0.436</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-tcrm-9-371"><p><bold>Note:</bold> Number of patients, particularly at 90 and 120 minutes, are less because patients who had temperatures within the normal range recovered and were discharged from hospital.</p></fn><fn id="tfn3-tcrm-9-371"><p><bold>Abbreviations:</bold> IV, intravenous; IM, intramuscular; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-tcrm-9-371" position="float"><label>Table 3</label><caption><p>Between-treatment comparisons of mean change from baseline in temperatures at different time points</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Time/temperature (minutes)</th><th align="left" valign="top" rowspan="1" colspan="1">IM diclofenac<break/>Mean &#x000b1; SD (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">Oral paracetamol<break/>Mean &#x000b1; SD (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1">IV paracetamol<break/>Mean &#x000b1; SD (95% CI)</th><th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.39 &#x000b1; 0.29 (&#x02212;0.34, &#x02212;1.5)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.45 &#x000b1; 0.36 (&#x02212;0.39, &#x02212;1.7)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.23 &#x000b1; 0.35 (&#x02212;0.17, &#x02212;2.5)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">60</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.99 &#x000b1; 0.34 (&#x02212;0.94, &#x02212;2.1)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.69 &#x000b1; 0.43 (&#x02212;0.61, &#x02212;1.7)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.01 &#x000b1; 0.40 (&#x02212;0.94, &#x02212;2.2)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.44 &#x000b1; 0.43 (&#x02212;1.4, &#x02212;2.5)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.08 &#x000b1; 0.51 (&#x02212;0.99, &#x02212;2.2)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.35 &#x000b1; 0.46 (&#x02212;1.3, &#x02212;3.1)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">120</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.81 &#x000b1; 0.46 (&#x02212;1.7, &#x02212;2.9)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.35 &#x000b1; 0.51 (&#x02212;1.3, &#x02212;2.5)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.63 &#x000b1; 0.55 (&#x02212;1.5, &#x02212;4.1)</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-tcrm-9-371"><p><bold>Note:</bold> Mean change from baseline = post baseline mean &#x02013; baseline mean 95% CI for mean change from baseline.</p></fn><fn id="tfn5-tcrm-9-371"><p><bold>Abbreviations:</bold> IV, intravenous; IM, intramuscular; SD, standard deviation; CI, confidence interval.</p></fn></table-wrap-foot></table-wrap></floats-group></article>